Svennilson Peter — SEC insider filings

SEC reporting owner CIK 1606074. 60 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers the 50 most recent of 60 filings on record, filed 2021-04-02 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eikon Therapeutics, Inc. (EIKN)10% owner24 legs · 2,206,960 sh · $39,150,725—14
NGM BIOPHARMACEUTICALS INC (NGM)10% owner2362 legs · 3,690,481 sh · $27,605,175—14
RAPT Therapeutics, Inc. (RAPT)10% owner128 legs · 1,278,450 sh · $13,686,78446 legs · 391,101 sh · $13,726,22426
Revolution Medicines, Inc. (RVMD)Director3—16 legs · 233,007 sh · $10,446,131—
Tenaya Therapeutics, Inc. (TNYA)10% owner3—12 legs · 9,400,290 sh · $5,927,199—
Surrozen, Inc./DE (SRZN)10% owner412 legs · 65,600 sh · $1,299,246—9
Nurix Therapeutics, Inc. (NRIX)10% owner1——15
Oric Pharmaceuticals, Inc. (ORIC)10% owner2——9

Insider filings — Svennilson Peter

FiledFormIssuerReported transactionsSource
2026-10-224Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 moreEDGAR
2026-09-084Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim
Purchase (P): 89,200 @ $11.56EDGAR
2026-02-264Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim
Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56EDGAR
2026-02-244Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim
Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60EDGAR
2026-02-124Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim
Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68EDGAR
2026-02-094Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim
Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 moreEDGAR
2026-01-204Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60EDGAR
2026-01-154Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99EDGAR
2026-01-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89EDGAR
2024-12-234RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative)EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2023-11-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62EDGAR
2023-02-014NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00EDGAR
2023-01-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 9,900 @ $5.00EDGAR
2023-01-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00EDGAR
2023-01-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 5,378 @ $4.95EDGAR
2023-01-124NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76EDGAR
2022-12-144NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 300 @ $4.98EDGAR
2022-11-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00EDGAR
2022-11-074NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72EDGAR
2022-10-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 76,877 @ $4.86EDGAR
2022-10-274NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85EDGAR
2022-06-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50EDGAR
2022-06-064NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03EDGAR
2022-06-024NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45EDGAR
2022-05-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45EDGAR
2022-05-274RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Purchase (P): 1,837 @ $12.45 · Purchase (P): 63 @ $12.45EDGAR
2022-05-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43EDGAR
2022-05-254RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Purchase (P): 9,898 @ $12.50 · Purchase (P): 338 @ $12.50 · Purchase (P): 15,776 @ $12.00 · Purchase (P): 538 @ $12.00EDGAR
2022-05-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48EDGAR
2022-05-194NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20EDGAR
2022-05-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90EDGAR
2022-05-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 moreEDGAR
2022-05-124RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Purchase (P): 1,208,750 @ $10.67 · Purchase (P): 41,250 @ $10.67EDGAR
2022-05-114NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36EDGAR
2022-01-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, Kutzkey Tim, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP
Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791EDGAR
2021-11-164Oric Pharmaceuticals, Inc. (ORIC)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, GOEDDEL DAVID V, Column Group LLC
Option exercise (M): 16,625 @ $16 · Other (J): 1,200,000 @ $0 · Other (J): 287,702 @ $0 · Other (J): 287,702 @ $0 · Other (J): 86,716 @ $0 · Other (J): 86,716 @ $0 · +2 moreEDGAR
2021-09-294RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Option exercise (M): 7,500 @ $28.27 · Sale (S): 7,500 @ $34.48 · Option exercise (M): 1,114 @ $22.20 · Sale (S): 1,114 @ $34.97 · Option exercise (M): 625 @ $19.30 · Sale (S): 625 @ $34.94 · +3 moreEDGAR
2021-09-164RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Sale (S): 1,400 @ $35.71 · Sale (S): 29,634 @ $36.79 · Sale (S): 25,351 @ $37.27 · Sale (S): 1,700 @ $35.77 · Sale (S): 42,151 @ $36.92 · Sale (S): 10,807 @ $37.31 · +7 moreEDGAR
2021-09-144RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Other (J): 1,166,666 @ $0 · Other (J): 279,710 @ $0 · Other (J): 279,710 @ $0 · Other (J): 72 @ $0 · Other (J): 84,307 @ $0 · Other (J): 84,307 @ $0 · +7 moreEDGAR
2021-09-034RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Sale (S): 6,904 @ $35.02 · Sale (S): 8,976 @ $35.39 · Sale (S): 8,805 @ $35.06 · Sale (S): 7,064 @ $35.46 · Sale (S): 18,545 @ $35.43 · Sale (S): 18,556 @ $35.43EDGAR
2021-08-244RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Sale (S): 1,440 @ $30.09 · Sale (S): 1,429 @ $30.08 · Sale (S): 1,670 @ $30.07 · Sale (S): 7,605 @ $30.93 · Sale (S): 12,969 @ $31.41 · Sale (S): 2,200 @ $32.35 · +12 moreEDGAR
2021-08-204RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V, Column Group LLC
Other (J): 1,317,005 @ $0 · Other (J): 208,403 @ $0 · Other (J): 208,403 @ $0 · Other (J): 91 @ $0 · Other (J): 64,425 @ $0 · Other (J): 64,425 @ $0 · +1 moreEDGAR
2021-06-244RAPT Therapeutics, Inc. (RAPT)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2021-06-174Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 16,625 (derivative) @ $0EDGAR
2021-05-074Nurix Therapeutics, Inc. (NRIX)
jointly with COLUMN GROUP L P
Other (J): 2,000,000 @ $0 · Other (J): 438,338 @ $0 · Other (J): 10,307 @ $0 · Other (J): 10,307 @ $0 · Other (J): 10,307 @ $0 · Other (J): 438,338 @ $0 · +9 moreEDGAR
2021-04-284Revolution Medicines, Inc. (RVMD)Sale (S): 24,883 @ $42.85 · Sale (S): 28,101 @ $42.85 · Sale (S): 10,955 @ $42.65 · Sale (S): 12,371 @ $42.65 · Sale (S): 47 @ $42.50 · Sale (S): 53 @ $42.50EDGAR
2021-04-124Revolution Medicines, Inc. (RVMD)Sale (S): 21,710 @ $44.80 · Sale (S): 24,518 @ $44.80 · Sale (S): 11,600 @ $43.83 · Sale (S): 13,101 @ $43.83EDGAR
2021-04-074Revolution Medicines, Inc. (RVMD)Sale (S): 8,554 @ $46.65 · Sale (S): 9,661 @ $46.65 · Sale (S): 18,551 @ $48.06 · Sale (S): 20,949 @ $48.06 · Sale (S): 13,128 @ $45.60 · Sale (S): 14,825 @ $45.60EDGAR
2021-04-024RAPT Therapeutics, Inc. (RAPT)Grant/award (A): 2,229 (derivative) @ $15.70EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1606074 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs